Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents
Thomas J. Walsh(Cornell University), Nicholas A. Kartsonis(Merck & Co., Inc., Rahway, NJ, USA (United States)), Cindy L. Schwartz(Brown University), Michael Neely(University of Southern California), Alisha Miller(United States Military Academy), Carole A. Sable(United States Military Academy), Nita L. Seibel(National Cancer Institute), Peter C. Adamson(University College London), Susan X. Li(United States Military Academy), Susan K. Bradshaw(United States Military Academy), Aziza Shad(Georgetown University), Maureen Roden(National Cancer Institute), Patricia M. Flynn(St. Jude Children's Research Hospital), Sheldon L. Kaplan(Baylor College of Medicine), Julie A. Stone(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 239
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k